It’s a complex program with many options — as well as confusing rules and nuances. Here’s how to get reliable guidance.
The law will ban the manufacture and sale in California of personal care products that contain 24 toxics, including asbestos, formaldehyde and lead, and is expected to fill a gap in federal regulation as companies sell the new formulations nationwide.
Eight months after California Healthline’s Heidi de Marco photographed LA under lockdown, she returned to the same iconic spots. Vehicle and foot traffic are up — as are coronavirus cases.
California’s ping-ponging approach to managing the pandemic — twice reopening large portions of the service sector economy only to shut them again — has residents and business owners on edge. But experts say the push and pull on businesses may be what success looks like in much of the U.S. for months to come, given COVID-19’s pervasive spread.
Activists across the country are demanding that medical schools eliminate the use of race as a diagnostic tool, recognize how systemic racism harms patients and reckon with some of medicine’s racist history.
While the Harvard Business School gently chided returnees to be on their best behavior, Stanford deployed green-vested enforcers and campus police who sometimes threatened students if they violated the rules. Both, apparently, succeeded.
California has more at stake than any other state should the U.S. Supreme Court strike down the Affordable Care Act. Millions of people could lose their health coverage and the state could lose billions in federal money each year.
Disneyland can’t reopen until Orange County’s coronavirus infection rates improve — especially among its poorest and most vulnerable residents. Local officials are protesting the requirements, saying the economy will suffer, and residents’ health along with it.
The U.S. Supreme Court will hear arguments Tuesday in a case that could overturn the Affordable Care Act. California Attorney General Xavier Becerra, who is defending the law with the backing of more than 20 other states, told California Healthline that he predicts the justices will uphold it.
Human clinical trials are scheduled for a drug that could prevent some of the 100,000-plus deaths from snakebites worldwide each year. The same drug may also help people suffering from COVID-related acute respiratory distress.